Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602

Clinical Oncology ◽

Randomised Trial ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Debulking Surgery ◽

Oncology Group Study ◽

Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.12.027 ◽

2009 ◽

Vol 113 (1) ◽

pp. 57-62 ◽

Cited By ~ 37

Author(s):

Takashi Onda ◽

Hiroaki Kobayashi ◽

Toru Nakanishi ◽

Masayuki Hatae ◽

Tsuyoshi Iwasaka ◽

...

Keyword(s):

Clinical Oncology ◽

Feasibility Study ◽

Stage Iii ◽

Oncology Group ◽

Debulking Surgery ◽

Oncology Group Study ◽

Phase III Trial of Upfront Debulking Surgery Versus Neoadjuvant Chemotherapy for Stage III/IV Ovarian, Tubal and Peritoneal Cancers: Japan Clinical Oncology Group Study JCOG0602

10.1093/jjco/hym145 ◽

2008 ◽

Vol 38 (1) ◽

pp. 74-77 ◽

Cited By ~ 37

Author(s):

T. Onda ◽

K. Matsumoto ◽

T. Shibata ◽

A. Sato ◽

H. Fukuda ◽

...

Keyword(s):

Clinical Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Debulking Surgery ◽

Phase Iii Trial ◽

Oncology Group Study

Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine (cape) in patients with stage III colon cancer (CC): Results of Japan Clinical Oncology Group study (JCOG0910).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.3512 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 3512-3512 ◽

Cited By ~ 3

Author(s):

Tetsuya Hamaguchi ◽

Yasuhiro Shimada ◽

Junki Mizusawa ◽

Yusuke Kinugasa ◽

Yukihide Kanemitsu ◽

...

Keyword(s):

Colon Cancer ◽

Adjuvant Chemotherapy ◽

Clinical Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Stage Iii Colon Cancer ◽

Phase Iii Study

Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine in patients with stage III colorectal cancer: Updated results of Japan Clinical Oncology Group study (JCOG0910)

Annals of Oncology ◽

10.1093/annonc/mdx393.012 ◽

2017 ◽

Vol 28 ◽

pp. v163

Author(s):

T. Hamaguchi ◽

Y. Shimada ◽

J. Mizusawa ◽

T. Sato ◽

T. Kato ◽

...

Keyword(s):

Colorectal Cancer ◽

Adjuvant Chemotherapy ◽

Clinical Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Phase Iii Study

Feasibility Study of Neoadjuvant Chemotherapy Followed by Interval Cytoreductive Surgery for Stage III/IV Ovarian, Tubal and Peritoneal Cancers: Japan Clinical Oncology Group Study JCOG0206

10.1093/jjco/hyh007 ◽

2004 ◽

Vol 34 (1) ◽

pp. 43-45 ◽

Cited By ~ 7

Author(s):

T. Onda

Keyword(s):

Clinical Oncology ◽

Feasibility Study ◽

Cytoreductive Surgery ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study

412P Six-year updated results of Japan Clinical Oncology Group study (JCOG0910): Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine in patients with stage III colorectal cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.08.523 ◽

2020 ◽

Vol 31 ◽

pp. S416-S417

Author(s):

T. Hamaguchi ◽

Y. Shimada ◽

J. Mizusawa ◽

Y. Kanemitsu ◽

A. Shiomi ◽

...

Keyword(s):

Colorectal Cancer ◽

Adjuvant Chemotherapy ◽

Clinical Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Phase Iii Study

Faculty of 1000 evaluation for Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812).

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717962364.793467463 ◽

2012 ◽

Author(s):

Steve Plaxe ◽

Kristy Ward

Keyword(s):

Ovarian Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Intraperitoneal Chemotherapy ◽

Phase Ii Study ◽

Advanced Ovarian Cancer ◽

Oncology Group ◽

Debulking Surgery ◽

Oncology Group Study ◽

Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND)

10.1093/jjco/hyy125 ◽

2018 ◽

Cited By ~ 2

Author(s):

Kiyo Tanaka ◽

Nobuhiro Hanai ◽

Junko Eba ◽

Junki Mizusawa ◽

Takahiro Asakage ◽

...

Keyword(s):

Neck Dissection ◽

Clinical Oncology ◽

Tongue Cancer ◽

Stage I ◽

Phase Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Phase Iii Study ◽

Prophylactic Neck Dissection

A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

10.1093/jjco/hyy004 ◽

2018 ◽

Vol 48 (4) ◽

pp. 392-395 ◽

Cited By ~ 25

Author(s):

Kohei Nakachi ◽

Masaru Konishi ◽

Masafumi Ikeda ◽

Junki Mizusawa ◽

Junko Eba ◽

...

Keyword(s):

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Tract Cancer

Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812)

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.10.001 ◽

2013 ◽

Vol 128 (1) ◽

pp. 22-27 ◽

Cited By ~ 3

Author(s):

Hiroshi Tsubamoto ◽

Yoshio Itani ◽

Kimihiko Ito ◽

Riichiro Kanazawa ◽

Shinji Toyoda ◽

...

Keyword(s):

Ovarian Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Intraperitoneal Chemotherapy ◽

Phase Ii Study ◽

Advanced Ovarian Cancer ◽

Oncology Group ◽

Debulking Surgery ◽

Oncology Group Study ◽